文献速递中毒与环境急症

羟嗪过量是否常见抗毒蕈碱效应?羟嗪与苯海拉明中毒患者抗毒蕈碱效应的队列分析

Are antimuscarinic effects common in hydroxyzine overdose? A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine-poisoned patients.
PubMed 文献 · Clin Toxicol (Phila) · 2023-05-17
一句话结论羟嗪中毒者抗毒蕈碱表现和需毒扁豆碱治疗的比例低于苯海拉明中毒者,更常见轻度中枢抑制;作者认为不应把苯海拉明中毒的疾病脚本套用到羟嗪。

该队列研究比较2000年1月1日至2020年12月31日美国国家中毒数据系统及2010年1月1日至2020年12月31日毒理研究者联盟核心登记中羟嗪与苯海拉明暴露。纳入单物质暴露且结局已知者,国家中毒数据系统排除慢性、非故意及年龄小于12岁者,毒理研究者联盟核心登记无排除标准。国家中毒数据系统纳入羟嗪17265例、苯海拉明102354例,毒理研究者联盟核心登记纳入羟嗪134例、苯海拉明1484例;两个数据集中羟嗪中毒者出现抗毒蕈碱表现或接受毒扁豆碱的比例及相对风险均较低,但毒理研究者联盟核心登记中高热例外。羟嗪中毒者昏迷/中枢神经系统抑制(重度)、呼吸抑制、癫痫发作、室性心律失常、插管及苯二氮䓬类给药更少,国家中毒数据系统中轻度中枢神经系统抑制更多;死亡率分别为0.02%和0.8%。

要点

  • 国家中毒数据系统(2000-2020)纳入羟嗪17265例、苯海拉明102354例,羟嗪中毒者抗毒蕈碱表现发生率及相对风险更低。
  • 毒理研究者联盟核心登记(2010-2020)纳入羟嗪134例、苯海拉明1484例,羟嗪中毒者抗毒蕈碱表现或接受毒扁豆碱的比例及相对风险更低,但高热例外。
  • 两数据集中羟嗪中毒者昏迷/中枢神经系统抑制(重度)、呼吸抑制、癫痫发作、室性心律失常、插管及苯二氮䓬类给药更少。
  • 国家中毒数据系统中羟嗪中毒者轻度中枢神经系统抑制比苯海拉明中毒者更常见。
  • 羟嗪中毒死亡罕见:国家中毒数据系统0.02%、毒理研究者联盟核心登记0.8%。

适用人群与场景

  • 单物质暴露且结局已知的羟嗪或苯海拉明中毒患者。
  • 国家中毒数据系统排除慢性暴露、非故意暴露及年龄小于12岁者;毒理研究者联盟核心登记无排除标准。

研究设计与关键结果

  • 研究类型为队列研究,比较2000年1月1日至2020年12月31日国家中毒数据系统及2010年1月1日至2020年12月31日毒理研究者联盟核心登记中的羟嗪与苯海拉明暴露。
  • 国家中毒数据系统纳入羟嗪17265例、苯海拉明102354例;毒理研究者联盟核心登记纳入羟嗪134例、苯海拉明1484例。
  • 两个数据集中羟嗪中毒者发生抗毒蕈碱表现或接受毒扁豆碱的比率及相对风险均低于苯海拉明中毒者,毒理研究者联盟核心登记中高热例外。
  • 羟嗪中毒者昏迷/中枢神经系统抑制(重度)、呼吸抑制、癫痫发作、室性心律失常、插管及苯二氮䓬类给药更少。
  • 国家中毒数据系统中羟嗪中毒者轻度中枢神经系统抑制比苯海拉明中毒者更常见。
  • 羟嗪中毒死亡率:国家中毒数据系统0.02%,毒理研究者联盟核心登记0.8%。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床医生不应将苯海拉明暴露的疾病脚本泛化到羟嗪暴露。
  • 羟嗪中毒者比苯海拉明中毒者更可能出现轻度中枢神经系统抑制,而非抗毒蕈碱中毒综合征。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Exposures to hydroxyzine, a first-generation H1 antihistamine, have increased rapidly over the last two decades. Many assumptions about hydroxyzine poisoning are based on other antihistamines, like diphenhydramine. However, the receptor affinities of hydroxazine suggest that there should be fewer antimuscarinic findings than diphenhydramine.

METHODS: This was a cohort study that compared hydroxyzine and diphenhydramine exposures reported to the National Poison Data System between January 1, 2000, and December 31, 2020, and the Toxicologic Investigators Consortium Core Registry between January 1, 2010, and December 31, 2020. The primary outcome was to assess for antimuscarinic findings in hydroxyzine-poisoned patients, using diphenhydramine-poisoned patients as a comparison group. The secondary outcomes were to assess for markers of overall toxicity. Inclusion criteria were single-substance exposures with known outcomes. Exclusion criteria for National Poison Data System exposures were chronic exposures, unintentional exposures, and patients younger than 12 years old. There were no exclusion criteria for exposures reported to the Toxicologic Investigators Consortium Core Registry.

RESULTS: There were 17,265 hydroxyzine and 102,354 diphenhydramine exposures reported to the National Poison Data System and 134 hydroxyzine and 1,484 diphenhydramine exposures reported to the Toxicologic Investigators Consortium Core Registry that met inclusion criteria. In both datasets, hydroxyzine-poisoned patients had lower rates and relative risk of developing antimuscarinic findings or receiving physostigmine, with the exception of hyperthermia in the Toxicologic Investigators Consortium Core Registry dataset. Coma/central nervous system depression (major), respiratory depression, seizures, ventricular dysrhythmias, intubation, and benzodiazepine administration were less likely in hydroxyzine-poisoned patients, but central nervous system depression (mild) was more likely in exposures reported to the National Poison Data System. The mortality in hydroxyzine-poisoned patients was rare: 0.02% and 0.8% of exposures reported to the National Poison Data System and Toxicologic Investigators Consortium Core Registry, respectively.

DISCUSSION: The clinical manifestations of hydroxyzine exposures are consistent with the pharmacology of hydroxazine. The clinical effects were consistent across two United States national datasets. Clinicians should not generalize the illness script of diphenhydramine exposures to hydroxyzine exposures.

CONCLUSIONS: Hydroxyzine-poisoned patients were less likely to develop antimuscarinic findings than diphenhydramine-poisoned patients. Hydroxyzine-poisoned patients were more likely to have mild central nervous system depression than an antimuscarinic toxidrome.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Simon M, Heard K. Are antimuscarinic effects common in hydroxyzine overdose? A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine-poisoned patients. Clin Toxicol (Phila). 2023. PMID: 37194685. doi:10.1080/15563650.2023.2200575

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。